Breastfeeding warning
Use during breastfeeding only on medical advice.
Medicine information BYDUREON 2mg prolonged-release suspension for injection in pen
Exenatide is a medication used in the treatment of type 2 diabetes, classified as a GLP-1 (glucagon-like peptide-1) receptor agonist. It helps control blood sugar levels by stimulating glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying, which lowers post-meal blood glucose levels.
Exenatide is available as an injectable solution and is administered either twice daily (immediate-release exenatide) or once weekly (extended-release exenatide). It is typically used in combination with other antidiabetic medications, such as metformin or sulfonylureas, when these alone are insufficient to control blood sugar. Additionally, exenatide may promote weight loss, an important benefit for overweight or obese patients with type 2 diabetes.
While effective, exenatide can cause side effects. The most common include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. In rare cases, more serious reactions may occur, such as acute pancreatitis, hypoglycemia (especially when used with sulfonylureas), or severe allergic reactions. It is important for patients to inform their doctor of any unusual symptoms or side effects.
Exenatide should be used as directed by a doctor, and patients should be regularly monitored to assess the effectiveness of the treatment and detect potential side effects. It is contraindicated in patients with a history of pancreatitis, severe renal impairment, or hypersensitivity to the active substance. Patients are also advised to maintain a balanced diet and engage in regular physical activity to optimize blood sugar control.
Exenatide is available as an injectable solution and is administered either twice daily (immediate-release exenatide) or once weekly (extended-release exenatide). It is typically used in combination with other antidiabetic medications, such as metformin or sulfonylureas, when these alone are insufficient to control blood sugar. Additionally, exenatide may promote weight loss, an important benefit for overweight or obese patients with type 2 diabetes.
While effective, exenatide can cause side effects. The most common include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. In rare cases, more serious reactions may occur, such as acute pancreatitis, hypoglycemia (especially when used with sulfonylureas), or severe allergic reactions. It is important for patients to inform their doctor of any unusual symptoms or side effects.
Exenatide should be used as directed by a doctor, and patients should be regularly monitored to assess the effectiveness of the treatment and detect potential side effects. It is contraindicated in patients with a history of pancreatitis, severe renal impairment, or hypersensitivity to the active substance. Patients are also advised to maintain a balanced diet and engage in regular physical activity to optimize blood sugar control.
General data about BYDUREON 2mg
- Substance:
- exenatide
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W64922001
- Strength:
- 2mg
- Pharmaceutical form:
- prolonged-release suspension for injection in pen
- Quantity:
- 4
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for exenatide
Strengths available for exenatide
- 10mcg/dose
- 2mg
- 5mcg/dose
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 05/07/2011
- Source record: last updated
- 21/11/2024
Warnings:
Pregnancy warning
Use during pregnancy only on medical advice.